Literature DB >> 12689395

Impact of ureteral stent diameter on symptoms and tolerability.

Erdal Erturk1, Annette Sessions, Jean V Joseph.   

Abstract

BACKGROUND AND
PURPOSE: Indwelling double-pigtail ureteral stents are frequently associated with debilitating symptoms. A randomized study was performed to evaluate the effect of stent diameter (4.7F v. 6F) on symptoms and tolerability. PATIENTS AND METHODS: Between February and October 2000, 46 consecutive patients undergoing ureteroscopy for stone disease were randomly assigned to receive either a 4.7F (group I) or a 6F (group II) ureteral stent following the procedure. The patients were asked to leave their stents in place for minimum of 7 days. Pain and irritative urinary symptoms in the two groups were compared according to a scale ranging from 0 (none) to 5 (severe). The two groups were also compared for stone size and location, rigid v. flexible ureteroscopy, anesthesia, stent migration, and ureteral dilation.
RESULTS: There were no differences between the groups in terms of pain (P = 0.28) or irritative symptoms (P = 0.37). There was a tendency for stents in group I to migrate distally and dislodge more often than those in group II (32% v 10%).
CONCLUSIONS: When stent insertion following ureteroscopy is deemed necessary, a minimum diameter of 6F is recommended.

Entities:  

Mesh:

Year:  2003        PMID: 12689395     DOI: 10.1089/08927790360587342

Source DB:  PubMed          Journal:  J Endourol        ISSN: 0892-7790            Impact factor:   2.942


  17 in total

Review 1.  Current status of ureteral stent technologies: comfort and antimicrobial resistance.

Authors:  Carlos E Mendez-Probst; Alfonso Fernandez; John D Denstedt
Journal:  Curr Urol Rep       Date:  2010-03       Impact factor: 3.092

Review 2.  Ureteral stent-associated complications--where we are and where we are going.

Authors:  Dirk Lange; Samir Bidnur; Nathan Hoag; Ben H Chew
Journal:  Nat Rev Urol       Date:  2014-12-23       Impact factor: 14.432

3.  Size does matter: ureteral stents with a smaller diameter show advantages regarding urinary symptoms, pain levels and general health.

Authors:  Sebastian Nestler; B Witte; L Schilchegger; J Jones
Journal:  World J Urol       Date:  2019-05-31       Impact factor: 4.226

4.  Freeze-casting porous chitosan ureteral stents for improved drainage.

Authors:  Kaiyang Yin; Prajan Divakar; Ulrike G K Wegst
Journal:  Acta Biomater       Date:  2018-11-07       Impact factor: 8.947

5.  Changes in Urinary Symptoms and Tolerance due to Long-term Ureteral Double-J Stenting.

Authors:  Jae-Sung Lim; Chong-Koo Sul; Ki-Hak Song; Yong-Gil Na; Ju-Hyun Shin; Tae-Hoon Oh; Young-Ho Kim
Journal:  Int Neurourol J       Date:  2010-08-31       Impact factor: 2.835

6.  Randomized, double-blind, placebo-controlled trial to compare solifenacin versus trospium chloride in the relief of double-J stent-related symptoms.

Authors:  Mohamed H Abdelhamid; Ahmed S Zayed; Waleed E Ghoneima; Akrm A Elmarakbi; Mohamed S El Sheemy; Ahmed Aref; Ahmed Abdelbary; Hani H Nour
Journal:  World J Urol       Date:  2017-01-03       Impact factor: 4.226

7.  Preoperative Belladonna and Opium Suppository for Ureteral Stent Pain: A Randomized, Double-blinded, Placebo-controlled Study.

Authors:  Franklin C Lee; Sarah K Holt; Ryan S Hsi; Brandon M Haynes; Jonathan D Harper
Journal:  Urology       Date:  2016-09-19       Impact factor: 2.649

Review 8.  Ureteral Stent Discomfort and Its Management.

Authors:  Katherine M Fischer; Michael Louie; Phillip Mucksavage
Journal:  Curr Urol Rep       Date:  2018-06-11       Impact factor: 3.092

9.  Is intravesical stent position a predictor of associated morbidity?

Authors:  Dominik Abt; Livio Mordasini; Elisabeth Warzinek; Hans-Peter Schmid; Sarah Roberta Haile; Daniel Stephan Engeler; Gautier Müllhaupt
Journal:  Korean J Urol       Date:  2015-04-24

10.  Complications and outcomes of JJ stenting of the ureter in urological practice: A single-centre experience.

Authors:  Mohammed S Al-Marhoon; Omar Shareef; Krishna P Venkiteswaran
Journal:  Arab J Urol       Date:  2012-10-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.